Committed to world-class research, our department continues to attract significant federal grants for groundbreaking work to improve the human condition. Since last July alone, our surgeon-scientists have been granted more than $13 million in new federal funds.
Here are some of the top grants our faculty have received:
Gavin Dunn, MD – R01 $2.26M
- NIH R01 NS 112712 – Targeting Neoantigens in Glioblastoma
- 09/15/19 – 06/30/24
- Total 5 year award $2.26M (directs + indirects)
Albert Kim, MD – R01 $2.1M
- NIH R01 NS 106612 – NAD+ Pathway Signaling in Glioblastoma Tumor Growth and Therapy Resistance
- 07/01/19 – 06/30/24
- Total 5 year award $2.1M (directs + indirects)
David Limbrick, MD/James (Pat) McAllister, MD – R21 $438K
- NIH R21 NS 111249 – Experimental endoscopic third ventriculostomy with choroid plexus cauterization and its effects on brain development
- 01/01/20 – 12/31/21
- Total 2 year award $438K (directs + indirects)
David Limbrick, MD – U01 subcontract $968K
- NIH U01 NS 107486 – Endoscopic versus Shunt Treatment of Hydrocephalus in Infants
- Subcontract from University of Utah
- 09/15/19 – 08/31/26
- Total 7 year award $968K (directs + indirects)
Wilson (Zack) Ray, MD – DoD $3.5M
- DoD – Nerve Transfers to improve upper extremity function and quality of life in tetraplegic patients
- 09/30/19 – 09/29/2023
- Total 4 year award $3.5M (directs + indirects)
Jennifer Strahle, MD – R01 $2.45M
- NIH R01 NS 110793 – Ependymal Dysfunction in Neonatal Post-Hemorrhagic Hydrocephalus
- 04/15/19 – 01/31/24
- Total 5 year award $2.45M (directs + indirects)
Hiroko Yano, MD – R01 $2M
- NIH R01 NS 111014 – Role of DNA methyltransferases in Huntington’s disease
- 05/01/19 – 04/30/24
- Total 5 year award $2M (directs + indirects)